According to UBS research report dated September 28, 2026, the S&P 500’s forward P/E ratio has declined 17% from its November peak last year, while the 10-year U.S. Treasury yield has risen approximately 100 basis points year-to-date to 5.2%, about 80 basis points above its one-year moving average. Over the past 40 years, the 10-year U.S. Treasury yield has exceeded 1.5 standard deviations only seven times. The current market is pricing in approximately 88 basis points of Fed rate hikes over the next year—close to, but below, the 100-basis-point threshold. UBS believes the Fed’s rate hike path will determine equity market direction. Historical data shows that if the Fed hikes rates by more than 100 basis points within a year, the S&P 500 tends to deliver negative returns one year later; if hikes are moderate, the index averages a 17.7% gain over the same period. Current pricing is closer to the moderate hiking scenario. The valuation framework suggests an implied upside of approximately 21% for the S&P 500. In terms of allocation, UBS recommends focusing on high-growth, low-valuation sectors such as semiconductors, pharmaceuticals, refining, and diversified banks.
UBS: S&P 500 Forward P/E Falls 17%; Fed Path to Determine Market Outlook
TechFlowShare
Summary
CFT measures have tightened global capital flows, impacting risk-on assets such as equities. UBS reported on September 28, 2026, that the S&P 500 forward P/E has declined 17% from its November 2025 peak. The 10-year U.S. Treasury yield has risen 100 basis points to 5.2%, exceeding the one-year moving average by 80 basis points. UBS noted that current pricing implies approximately 88 basis points of Fed rate hikes over the next year, below the 100-basis-point threshold. Historically, the S&P 500 has tended to deliver negative returns when the Fed raises rates by more than 100 basis points in a year. UBS suggests a valuation framework indicates about 21% upside potential for the S&P 500 and recommends focusing on high-growth, low-valuation sectors such as semiconductors, pharmaceuticals, refining, and diversified banking.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.